Michelle Finnegan
- Psychiatry and Mental health top 1%
- Pathology and Forensic Medicine top 2%
- Physiology top 5%
- Health, Toxicology and Mutagenesis top 5%
- Pulmonary and Respiratory Medicine
- Co-authors
- Joel M. TrugmanRichard B. LiptonJessica AilaniSherwood BurgeChristopher PickeringKaifeng LuDavid W. DodickArmin Szegedi
- Topics
- Migraine and Headache Studies (32 papers)Botulinum Toxin and Related Neurological Disorders (10 papers)Neurological Disorders and Treatments (8 papers)
- Cited by
- Psychiatry and Mental healthPathology and Forensic MedicineHealth, Toxicology and Mutagenesis
- Partner nations
- United StatesUnited KingdomDenmark
In The Last Decade
Michelle Finnegan
41 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 114
- Psychiatry and Mental health 1.1k
- Pathology and Forensic Medicine 698
- Physiology 411
- Health, Toxicology and Mutagenesis 285
- Pulmonary and Respiratory Medicine 154
Countries citing papers authored by Michelle Finnegan
This map shows the geographic impact of Michelle Finnegan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Finnegan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Finnegan more than expected).
Fields of papers citing papers by Michelle Finnegan
This network shows the impact of papers produced by Michelle Finnegan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Finnegan. The network helps show where Michelle Finnegan may publish in the future.
Co-authorship network of co-authors of Michelle Finnegan
This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Finnegan. A scholar is included among the top collaborators of Michelle Finnegan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Finnegan. Michelle Finnegan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 4 | |
| 3 | 3 | |
| 4 | 48 | |
| 5 | Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trialbreakdown → | 75 |
| 6 | 36 | |
| 7 | 3 | |
| 8 | 1 | |
| 9 | 0 | |
| 10 | 3 | |
| 11 | 5 | |
| 12 | 9 | |
| 13 | 2 | |
| 14 | 14 | |
| 15 | 3 | |
| 16 | 42 | |
| 17 | 85 | |
| 18 | 4 | |
| 19 | 46 | |
| 20 | 268 |
About Michelle Finnegan
Michelle Finnegan is a scholar working on Psychiatry and Mental health, Sensory Systems and Neurology, having authored 43 papers that have together received 1.6k indexed citations. Recurring topics across this work include Migraine and Headache Studies (32 papers), Botulinum Toxin and Related Neurological Disorders (10 papers) and Neurological Disorders and Treatments (8 papers). The work is most often cited by research in Psychiatry and Mental health (1.1k citations), Pathology and Forensic Medicine (698 citations) and Health, Toxicology and Mutagenesis (285 citations). Michelle Finnegan has collaborated with scholars based in United States, United Kingdom and Denmark. Frequent co-authors include Joel M. Trugman, Richard B. Lipton, Jessica Ailani, Sherwood Burge, Christopher Pickering, Kaifeng Lu, David W. Dodick, Armin Szegedi, Lawrence Severt and Peter J. Goadsby. Their work appears in journals such as New England Journal of Medicine, The Lancet and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.